Oral Anticoagulation Therapy : Cases and Clinical Correlation
https://libcat.nshealth.ca/en/permalink/provcat41753
Kathryn Kiser, editor.
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to dev…
- Available Online
- View e-Book
- Other Authors
- Kiser, Kathryn
- Responsibility
- Kathryn Kiser, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (x, 313 pages) : 6 illus., 2 illus. in color
- ISBN
- 9783319546438
- 9783319546414 (print ed.)
- Subjects (MeSH)
- Administration, Oral
- Anticoagulants - therapeutic use
- Hemorrhage - drug therapy
- Vascular Diseases - drug therapy
- Warfarin - therapeutic use
- Abstract
- This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to develop their knowledge base, problem-solving skills, and ability to practically apply new knowledge to a variety of clinical situations. Resources provided in cases include valuable figures, tables, and key points designed for the reader to be able to utilize at the point of care.
- Contents
- Part I: Introduction -- 1. Introduction -- Part II: Atrial Fibrillation -- 2. CHA2DS2-VASc and HAS-BLED Risk Stratification Tools -- 3. Male with Priority of Ischemic Stroke Reduction -- 4. Choosing an Anticoagulant in an Elderly Patient -- 5. Patient with Prior History of GI Hemorrhage -- 6. Patients with a History of Intracranial Hemorrhage -- 7. Concerns with Anticoagulant Adherence -- 8. Oral Anticoagulants in Stable Moderate Chronic Kidney Disease -- 9. Oral Anticoagulants in Severe Renal Dysfunction -- 10. Oral Anticoagulants in Patients with Variable Renal Function -- 11. Patient with Concomitant Stable Coronary Artery Disease -- 12. Patient with Concomitant Acute Venous Thromboembolism -- 13. Patient with Concomitant Mitral Valve Stenosis -- 14. Patient with Concomitant Aortic Valve Stenosis -- Part III: Warfarin Management -- 15. Best Practice for Switching Stable Warfarin Patients -- 16. Patient-Centered Strategies for Improving Warfarin Management -- Part IV: Venous Thromboembolism (VTE) -- 17. Provoked Versus Unprovoked Venous Thromboembolism -- 18. Venous Thromboembolism (VTE) Prophylaxis in Hip and Knee Replacement Surgery -- 19. Venous Thromboembolism (VTE) Prophylaxis in the Intensive Care Unit (ICU) -- 20. VTE and Recent Drug Eluting Stent (DES) Placement -- 21. Acute VTE in a Patient with Moderate Chronic Kidney Disease -- 22. Oral Anticoagulation and Duration in Recurrent Venous Thromboembolism (VTE) -- 23. Pulmonary Embolism (PE) with Thrombolytic Therapy -- Part V: Acute Coronary Syndrome (ACS) -- 24. Patient on Oral Anticoagulant Presenting with ACS -- 25. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention -- 26. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant -- 27. ACS with Bypass Surgery -- Part VI: Drug Interactions -- 28. Anticoagulant Drug-Drug Interactions with CYP 3A4 Inhibitors -- 29. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions -- 30. Considerations with Pharmacodynamic Drug-Drug Interactions -- 31. Management of Direct Oral Anticoagulants with Mixed P-gp/3A4 Drug-Drug Interactions -- 32. Pharmacokinetic Drug-Drug Interactions with Warfarin -- Part VII: Special Populations -- 33. Chronic Pain Management with Anticoagulation -- 34. Anticoagulation Management in Atrial Fibrillation Catheter Ablation -- 35. Anticoagulation Management Considerations for Mechanical Valves -- 36. Management of Antiphospholipid Antibody Syndrome -- 37. Venous Thromboembolism and Pregnancy -- 38. Venous Thromboembolism in Active Malignancy -- 39. Anticoagulation Management in Patients Undergoing Gastric Bypass Procedures -- 40. Patient Presenting with Minor Bleeding -- 41. Patient Presenting with Major, Life-Threatening Bleeding -- 42. Overdose of Dabigatran.
- Format
- e-Book
- Location
- Online
